H1N1 Global Status as on 17^th November’2009

Swine flue, after first detection in Mexico City 18^th March 2009 has since spread over the globe including all the states of USA. According to World Health Organization (WHO) report of 13^th November this year, the world figure of laboratory confirmed cases of H1N1 were more than 503,000 resulting in 6260 deaths in 206 countries. However the majority of cases were from USA and Brazil. As per WHO regional office for Americas (AMRO), the clinically confirmed cases of H1N1 infection for whole of America was 190,765 with a death toll of 4512. The number count of sickened cases actually is much more than the above all-world figure suggests, as many of the countries as well as WHO has stopped counting individual sickness cases as the numbers went on rising quickly and instead started tracking major outbreaks. WHO has declared the swine flue outbreak a pandemic on June 11 this year.

The global status of confirmed deaths in the H1N1 pandemic, as per report of European Centre for Disease Prevention and Control (ECDC) as on 17^th November is given below in short.

1. European Union and EFTA……………………………………………. 515

2. Other European countries and Central Asia………………………… 63

3. Mediterranean and Middle East ……………………………………… 368

4 .Africa…………………………………………………………………….. 108

5. North America………………………………………………………….. 1766

6. Central America and Caribbean……………………………………… 170

7. South America…………………………………………………………. 2760

8. Asia……………………………………………………………………… 1128

9. Australia and Pacific countries……………………………………….. 214

————-

7092

The WHO is pro-actively monitoring the progress of the pandemic with the input from its regional offices, member countries and other multiple source data.

Effect of Spread of Swine Flue Pandemic on Economy

The pandemic has hit the world at a time when the world economy is just staging a turnaround. The productivity of a nation depends on its healthy population. If large number of people report sick because of swine flue, then productivity is bound to drop. This directly hits at the core of the economy. The other most suffering sector is tourism. Because of swine flue scare, tourists are cutting down their itinerary or altogether dropping it to keep indoors. Countries having lesser or no instances of swine flue imposes travel ban on foreigners. Even export of meat is banned by some countries in the fear of contaminated meat etc. The stock prices of tourist industries including aviation may slide. The present pandemic flue too has done its share of economic damage to the US and world at large.

During the investigation which led to nine arrests, 11 properties being searched and the seizure of 15,000 counterfeit pills for erectile dysfunction.
The tablets and various different kinds of pills, which were sold over the Internet and in a handful of Montreal sex shops, resemble the regular varieties available by prescription. The same looking versions are more or less identical in size, shape and colour to Viagra manufactured by Pfizer.

Other than the counterfeit drugs, police also seized 50 lbs. of marijuana, and some firearms and a small amount of cash during raids on Thursday.

The group’s leaders are believed to be among the six men and two women that were arrested. It is very likely that they may face a string of fraud charges, including conspiracy to commit fraud, trademark counterfeiting and distribution of copyrighted material.

The main objective of this news is POISONING DANGER and in addition to being illegal, these bogus medications could lead to harmful side-effects.

“Most of the cases, there are no active (medical) ingredients, and in others the dosage is too high,” explained Health Canada’s Sylvie Cantin. “In the worst cases, poisoning is possible.”

Cantin suggested to people to be on their guard and always make sure the container of the product they’re buying includes an eight-digit code that starts with DIN or NPN.

The representative of RCMP’s federal investigation branch Noel Saint-Hilaire, cautioned against buying any drugs or medications over the Internet. “Buying medication over the Internet other than the a pharmacy, it’s inevitably going to be counterfeit,” she said. There are only few online pharmacies which have their reputation of dispensing quality medicines and bind to ethics such as www.genericmedicine.com

It is now a growing trend and has become a major concern to law enforcement as the commercialization of counterfeit drugs and medication as a growing trend.

It is very much ascertained the counterfeit versions of cancer medication, heart drugs and even appetite suppressants are sold widely on the black market, which includes the Internet,” Saint-Hilaire added. Be sure that you get your quality generic medicine from a reputed online pharmacy such as genericmedicine.com

Health regulatory world wide is informing health professionals of an ongoing safety review of the potential association between the diabetes drug Lantus (insulin glargine) and an increased risk of developing cancer.

A similar review was recently announced by the United States Food and Drug Administration and the European Medicines Agency in light of four recently published studies that looked at the use of Lantus and the development of various types of cancer in patients with diabetes.

There were four studies conducted and three results suggested a very slightly increased risk of cancer associated with use of Lantus, while the fourth study found no link between the drug and the development of cancer. All studies showed that the number of patients who developed cancer was small. The four studies were published in Diabetologia.

Lantus is a drug which is long-acting synthetic insulin similar to human insulin that is used to control blood sugar in people with type 1 and type 2 diabetes. It has been marketed world wide by the company Sanofi-Aventis.

At this time, Health regulators have recommended that patients should not stop taking their insulin therapy without first consulting their physician, as uncontrolled blood sugar can have both immediate and long term serious health consequences. Patients should and must contact their health care professional if they have any concerns about the medicines they are taking.

Health regulators have not concluded that there is a relationship between Lantus and the development of cancer. The health department is currently assessing available safety data, including the studies, to better understand the risk, if any. Health regulators will inform health care professionals of new safety information as it emerges, as appropriate.

There are several other generic diabetes drugs available on generic medicine.com such as generic actos which is pioglitizone, generic ACTOSPlus Met which is combination pill that contains Actos + Metformin in the same pill, generic Amaryl which is glimepiride, generic Avandia which is rosiglitazone, generic Avandamet which is rosiglitazone maleate and metformin hydrochloride, generic Byetta which is Exantide, generic Duetact which is pioglitazone HCl and glimepiride, generic Galvus which is Vildagliptin, generic Glipizide, generic Glucophage which is metformin, generic Januvia which is sitagliptin phosphate, generic Starlix which is nateglinide and so on.

This double dose plan-B is already available in India. You will already find it listed in our Price List (www.genericmedicine.com).

Supplied Product Name- iPill (1.5mg tablet) from Cipla Ltd, India.

As FDA approves single-dose Plan B, Teva touts advantages

17 July 2009 by Nancy Faigen

Teva Pharmaceutical Industries has recently received approval from the US FDA to market its emergency contraceptive Plan B (levonorgestrel) in a new dosage formulation that requires a single 1.5mg tablet, instead of two 0.75mg tablets which need to be taken 12 hours apart. Teva touts as an advantage the fact that the new formulation, Plan B One-Step, can be taken “right away” after unprotected sex has occurred. It is known that Emergency contraception is more effective the sooner it is taken. Plan B One-Step is expected to be in retail pharmacies in August, Teva said. The new formulation will replace the two-pill formulation in Teva’s product line just as the original Plan B product loses its US exclusivity (as an OTC product) on August 24th. Pricing of the new single-tablet formulation has not been announced, but industry observers believe it might be similar to the original Plan B product, which costs $49.99 on the on-line retailer drugstore.com. In addition to approving the single-dose emergency contraceptive, the FDA has also expanded OTC access to both Plan B One-Step and the original two-dose Plan B, and will make them available to consumers age 17 or older. The FDA said in April it would provide no objections to a judge’s order to allow the OTC sales to 17-year olds (scripnews.com, April 24th, 2009). Both products will be available for women younger than 17 years of age only by prescription. Many healthcare workers view the original Plan B product as posing limitations, because it requires careful timing that may not be convenient for a patient. Jennifer Rogers who is the acting executive director for Reproductive Health Technologies Project, told Newsweek, “Sometimes, with two doses, women would delay taking their first pill. If you buy it at 2pm, but don’t want to wake up at 2am, you may wait another six hours to begin the course of treatment.” She added, “For us, one pill makes the most sense.”The US data sheet for Plan B One-Step outlines the clinical efficacy of the new formulation. It states: “In the Plan B Step-One group, 16 pregnancies occurred in 1,198 women and in the Plan B group, 20 pregnancies occurred in 1,183 women. The number of pregnancies expected in each group was calculated based on the timing of intercourse with regard to each woman’s menstrual cycle. Among women receiving Plan B One-Step, 84% of expected pregnancies were prevented and among those women taking Plan B, 79% of expected pregnancies were prevented. The expected pregnancy rate of 8% (with no contraceptive use) was reduced to approximately 1% with Plan B One-Step.” Last month, the FDA approved the first ANDA for the two-dose formulation, from Watson Laboratories. Watson plans to launch its generic product shortly, under the trade name Next Choice. For now, its two-dose 0.75mg formulation will only be available by prescription. Visit genericmedicine.com to buy this product

Buy double dose plan-B from www.genericmedicine.com